27693-37-4 Usage
Yellow crystalline solid
This describes the physical appearance of the compound, which is a yellow solid with a crystalline structure.
Molecular weight
220.2 g/mol This is the mass of one mole of the compound, which is a measure of its size and stability.
Versatile reactivity
This refers to the compound's ability to undergo chemical reactions with a variety of other compounds, making it useful in the synthesis of pharmaceuticals and organic compounds.
Application in the production of dyes, pigments, and other organic materials
This indicates that the compound is used in the production of various materials, including dyes and pigments, due to its chemical properties.
Potential medicinal properties
This suggests that the compound has been studied for its potential therapeutic uses, including as an anti-inflammatory and antiviral agent.
Practical applications in the fields of chemistry, pharmaceuticals, and materials science
This highlights the compound's relevance and use in various scientific fields, making it an important chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 27693-37-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,6,9 and 3 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 27693-37:
(7*2)+(6*7)+(5*6)+(4*9)+(3*3)+(2*3)+(1*7)=144
144 % 10 = 4
So 27693-37-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H8N2O3/c15-12(10-6-3-4-8-13-10)9-5-1-2-7-11(9)14(16)17/h1-8H
27693-37-4Relevant articles and documents
Synthesis of aryl(di)azinyl ketones through copper- and iron-catalyzed oxidation of the methylene group of aryl(di)azinylmethanes
De Houwer, Johan,Abbaspour Tehrani, Kourosch,Maes, Bert U. W.
supporting information; experimental part, p. 2745 - 2748 (2012/04/10)
Sustainable Oxidations: An oxidation method to transform aryl(di)azinylmethanes into aryl(di)azinyl ketones is described. Base metals (copper and iron) as catalysts in combination with O2 as the oxidant are used, which makes this method sustainable. The utility of this method is illustrated by the synthesis of 6-(4-methylbenzoyl)pyridine-2-carbaldehyde, which is an intermediate in the preparation of the drug Acrivastine. Copyright
